Atsena Advances XLRS Gene Therapy - Top-Institutions - MDSpire

Atsena Advances XLRS Gene Therapy

Atsena Therapeutics dose first patient in pivotal XLRS gene therapy trial

  • June 30, 2026

  • 2 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Casey Eye Institute at Oregon Health & Science University
    Casey Eye Institute at Oregon Health & Science University

    Portland, Oregon

    Key Differentiators

    • Ophthalmology

  • #2

    Scheie Eye Institute at the University of Pennsylvania
    Scheie Eye Institute at the University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology

Original Source(s)

Atsena Advances XLRS Gene Therapy

  • June 30, 2026

Related Content

The risk association between systemic lupus erythematosus and glaucoma: a systematic review and meta-analysis

Effect of RAS inhibitors on retinal microvasculature in DKD using AI-based ultra-wide-field images

EGS Leaders Chart the Future of Glaucoma Care

Incoming and outgoing EGS presidents discuss the technologies, challenges, and priorities shaping the future of glaucoma care